DNTH
Price
$19.04
Change
-$0.99 (-4.94%)
Updated
Jul 15 closing price
Capitalization
612.33M
SLRN
Price
$2.27
Change
+$0.04 (+1.79%)
Updated
May 20 closing price
Capitalization
229.16M
34 days until earnings call
Interact to see
Advertisement

DNTH vs SLRN

Header iconDNTH vs SLRN Comparison
Open Charts DNTH vs SLRNBanner chart's image
Dianthus Therapeutics
Price$19.04
Change-$0.99 (-4.94%)
Volume$176.06K
Capitalization612.33M
ACELYRIN
Price$2.27
Change+$0.04 (+1.79%)
Volume$4.08M
Capitalization229.16M
DNTH vs SLRN Comparison Chart in %
Loading...
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNTH vs. SLRN commentary
Jul 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNTH is a Hold and SLRN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 17, 2025
Stock price -- (DNTH: $19.04 vs. SLRN: $2.27)
Brand notoriety: DNTH and SLRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNTH: 57% vs. SLRN: 109%
Market capitalization -- DNTH: $638.05M vs. SLRN: $229.16M
DNTH [@Biotechnology] is valued at $638.05M. SLRN’s [@Biotechnology] market capitalization is $229.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $300.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNTH’s FA Score shows that 0 FA rating(s) are green whileSLRN’s FA Score has 0 green FA rating(s).

  • DNTH’s FA Score: 0 green, 5 red.
  • SLRN’s FA Score: 0 green, 5 red.
According to our system of comparison, DNTH is a better buy in the long-term than SLRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNTH’s TA Score shows that 5 TA indicator(s) are bullish while SLRN’s TA Score has 1 bullish TA indicator(s).

  • DNTH’s TA Score: 5 bullish, 5 bearish.
  • SLRN’s TA Score: 1 bullish, 0 bearish.
According to our system of comparison, SLRN is a better buy in the short-term than DNTH.

Price Growth

DNTH (@Biotechnology) experienced а +4.33% price change this week, while SLRN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.70%. For the same industry, the average monthly price growth was +10.20%, and the average quarterly price growth was +39.68%.

Reported Earning Dates

DNTH is expected to report earnings on May 12, 2025.

SLRN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+2.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNTH($612M) has a higher market cap than SLRN($229M). DNTH YTD gains are higher at: -12.661 vs. SLRN (-27.707). DNTH has higher annual earnings (EBITDA): -116.76M vs. SLRN (-324.52M). SLRN has more cash in the bank: 562M vs. DNTH (263M). DNTH has less debt than SLRN: DNTH (1.4M) vs SLRN (6.56M). DNTH has higher revenues than SLRN: DNTH (6.52M) vs SLRN (0).
DNTHSLRNDNTH / SLRN
Capitalization612M229M267%
EBITDA-116.76M-324.52M36%
Gain YTD-12.661-27.70746%
P/E Ratio3.24N/A-
Revenue6.52M0-
Total Cash263M562M47%
Total Debt1.4M6.56M21%
FUNDAMENTALS RATINGS
DNTH: Fundamental Ratings
DNTH
OUTLOOK RATING
1..100
69
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNTHSLRN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 14 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL209.110.49
+0.23%
Apple
SPY622.14-2.67
-0.43%
SPDR® S&P 500® ETF
BTC.X117777.190000-2072.515600
-1.73%
Bitcoin cryptocurrency
TSLA310.78-6.12
-1.93%
Tesla
GME23.22-0.48
-2.03%
GameStop Corp

DNTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-4.94%
IMNM - DNTH
52%
Loosely correlated
-1.29%
XNCR - DNTH
50%
Loosely correlated
-4.63%
ERAS - DNTH
48%
Loosely correlated
-3.42%
CRNX - DNTH
48%
Loosely correlated
-3.60%
SYRE - DNTH
47%
Loosely correlated
-6.70%
More

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
N/A
CMND - SLRN
38%
Loosely correlated
-1.70%
THAR - SLRN
36%
Loosely correlated
-0.59%
STOK - SLRN
35%
Loosely correlated
-2.57%
CGEM - SLRN
35%
Loosely correlated
-5.34%
DNTH - SLRN
32%
Poorly correlated
-4.94%
More